J.P. Morgan: UCB Heralds ‘Long-Dated Patent Protection’ On Growth Drivers

Jean-Christophe Tellier, CEO of UCB
Jean-Christophe Tellier • Source: EFPIA
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from J.P. Morgan

More from Conferences